Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5985842 | 1.00 | FAAH (0.31) | FAAHTRPV1 | |
| SCHEMBL5985900 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL5985772 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL5984821 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL5984319 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL5984429 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL3209946 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL5986526 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL5984984 | 0.97 | FAAH (0.35) | FAAHTRPV1 | |
| SCHEMBL5985438 | 0.97 | FAAH (0.35) | FAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| EP-2610308-B1 | USE OF POLYCARBOSILANE AS DISPERSANT FOR FLUOROPOLYMERS IN POLYCARBONATE RESINS | MITSUBISHI ENG PLASTICS CORP (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-2570458-B1 | POLYCARBONATE RESIN COMPOSITION AND FORMED PRODUCT THEREOF | MITSUBISHI ENG PLASTICS CORP (JP) | 2019-05-15 | — | — | EP | disclosed |
| US-8802758-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-08-12 | — | — | US | disclosed |
| US-8785528-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-07-22 | — | — | US | disclosed |
| US-8772385-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-07-08 | — | — | US | disclosed |
| EP-2743314-A1 | Polycarbonate resin composition and molded object thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-06-18 | — | — | EP | disclosed |
| US-8729180-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-05-20 | — | — | US | disclosed |
| US-8710129-B2 | Polycarbonate resin composition and formed product thereof | MITSUBISHI ENGINEERING-PLASTICS CORPORATION (JP) | 2014-04-29 | — | — | US | disclosed |
| US-20050009785-A1 | Heterocyclic compounds | KUWABARA KENJI (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20050009892-A1 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20040162325-A1 | Heterocyclic compounds | KUWABARA KENJI (JP) | 2004-08-19 | — | — | US | disclosed |
| US-20040033434-A1 | Sulfonium salt compound | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2004-02-19 | — | — | US | disclosed |
| US-20030166697-A1 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2003-09-04 | — | — | US | disclosed |
| US-20030158164-A1 | Novel antiandrogenic agent | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-08-21 | — | — | US | disclosed |
| EP-1314725-A1 | SULFONIUM SALT COMPOUND | Wako Pure Chemical Industries, Ltd. (JP) | 2003-05-28 | — | — | EP | disclosed |
| EP-1304334-A1 | NOVEL ANTIANDROGENIC AGENT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-04-23 | — | — | EP | disclosed |
| EP-1295875-A1 | HETEROCYCLIC COMPOUNDS | Nippon Shinyaku Co., Ltd. (JP) | 2003-03-26 | — | — | EP | disclosed |
| EP-1219631-A1 | ANTIANDROGEN AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2002-07-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009785-A1 | Heterocyclic compounds | LIPC, GPR119, APOB | FAAH 910/4885TRPV1 1657/4885 |
| US-20050009892-A1 | Heterocyclic compounds | GPR119, LIPC, LIPE | FAAH 831/4885TRPV1 1285/4885 |
| US-20040162325-A1 | Heterocyclic compounds | LIPE, GPR119, LIPC | FAAH 633/4885TRPV1 1800/4885 |
| US-20030166697-A1 | Heterocyclic compounds | LIPE, GPR119, LIPC | FAAH 633/4885TRPV1 1800/4885 |
| US-20030158164-A1 | Novel antiandrogenic agent | NR5A1, CYP19A1, HSD17B11 | FAAH 1409/4885TRPV1 4436/4885 |
| US-20040033434-A1 | Sulfonium salt compound | SPIN1, RER1, SPIN2B | FAAH 2990/4885TRPV1 1472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.